pDONR223_TP53_WT Citations (1)
Originally described in: High-throughput Phenotyping of Lung Cancer Somatic Mutations.Berger AH, Brooks AN, Wu X, Shrestha Y, Chouinard C, Piccioni F, Bagul M, Kamburov A, Imielinski M, Hogstrom L, Zhu C, Yang X, Pantel S, Sakai R, Watson J, Kaplan N, Campbell JD, Singh S, Root DE, Narayan R, Natoli T, Lahr DL, Tirosh I, Tamayo P, Getz G, Wong B, Doench J, Subramanian A, Golub TR, Meyerson M, Boehm JS Cancer Cell. 2016 Aug 8;30(2):214-28. doi: 10.1016/j.ccell.2016.06.022. Epub 2016 Jul 28. PubMed Journal
Articles Citing pDONR223_TP53_WT
| Articles |
|---|
| Acquired On-Target Alterations Drive Clinical Resistance to p53-Y220C Reactivators. Fece de la Cruz F, Varkaris A, Patel PS, Kushner EW, Morales-Giron AA, Lee SS, Singh A, Kim CT, Norden BL, Ehnstrom S, Riedl JM, Curtis JM, Barnes H, Kehlmann AM, Chevalier NJ, Okuma HS, Patel M, Wirth LJ, Connell B, Nugent F, Pappas L, Lau K, Juric D, Hopkins JL, Guiley KZ, Shokat KM, Gulhan DC, Parikh AR, Corcoran RB. Cancer Discov. 2026 Apr 1;16(4):677-685. doi: 10.1158/2159-8290.CD-25-1761. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.